glp 1 keep weight off 45% a year after stopping GLP-1 drugs, study finds GLP-1 Maintenance: Why Keeping Weight

10.18632/oncotarget.25794 29

Prostaglandins Leukot Essent Fatty Acids 88 , 4347

The incorporation of a ruthenium catalyst and carbon fluorinated moieties into polymeric nanoreactors is expected to provide an anticancer strategy for tumor-targeted catalytic anticancer therapy of hypoxic tumors

I think this will exist and expand beyond the shortage dynamics

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin

Both NF-B signaling and mtROS promote NLPR3 inflammasome assembly, a key driver of neuroinflammation that leads to cleavage of precursor cytokines into biologically active pro-inflammatory cytokines, IL-1 and IL-18 (Blevins et al., 2022)